ConductScience.org, home

Paper39940134

Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.

Spada A and 1 other. Nanomaterials (Basel), 2025. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting. Papers, record 39940134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39940134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.
PubMed
Journal
Nanomaterials (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
10.38, provisional
iCite
Revised in PubMed
2025-02-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spada AAlessandra
2Gerber-Lemaire SSandrinehttps://orcid.org/0000-0002-6519-2782

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
200021E_205754Swiss National Science FoundationSwitzerlandPubMed

Source PubMed

Download CSV of grants

References320

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133390415Epidermal Growth Factor-gold Nanoparticle Conjugates-induced Cellular Responses: Effect of Interfacial Parameters between Cell and Nanoparticle.Anal Sci2021https://conductscience.org/library/papers/33390415PubMed
237814270Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.Mol Cancer2023https://conductscience.org/library/papers/37814270PubMed
321627112Biomedical applications of tetrazine cycloadditions.Acc Chem Res2011https://conductscience.org/library/papers/21627112PubMed
412651129Immobilization and surface characterization of NeutrAvidin biotin-binding protein on different hydrogel interlayers.J Colloid Interface Sci2003https://conductscience.org/library/papers/12651129PubMed
534853120Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis of Proteins.Cold Spring Harb Protoc2021https://conductscience.org/library/papers/34853120PubMed
610862985Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase.J Biotechnol2000https://conductscience.org/library/papers/10862985PubMed
737114242A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.Oncoimmunology2023https://conductscience.org/library/papers/37114242PubMed
822586147Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition.J Nucl Med2012https://conductscience.org/library/papers/22586147PubMed
936321150Mapping the relationship between total and functional antibodies conjugated to nanoparticles with spectrally-resolved direct stochastic optical reconstruction microscopy (SR-dSTORM).Nanoscale Adv2022https://conductscience.org/library/papers/36321150PubMed
1039525567Recent advances in aptamer discovery, modification and improving performance.Biochem Biophys Rep2024https://conductscience.org/library/papers/39525567PubMed
1118698735Cu-catalyzed azide-alkyne cycloaddition.Chem Rev2008https://conductscience.org/library/papers/18698735PubMed
1239154445A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency.J Colloid Interface Sci2025https://conductscience.org/library/papers/39154445PubMed
1332498278Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles.Pharmaceutics2020https://conductscience.org/library/papers/32498278PubMed
1439468359Targeted protein degradation via cellular trafficking of nanoparticles.Nat Nanotechnol2025https://conductscience.org/library/papers/39468359PubMed
1515880677Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein.Chembiochem2005https://conductscience.org/library/papers/15880677PubMed
1611433435Click Chemistry: Diverse Chemical Function from a Few Good Reactions.Angew Chem Int Ed Engl2001https://conductscience.org/library/papers/11433435PubMed
1718581754Epidermal growth factor therapy and wound healing--past, present and future perspectives.Surgeon2008https://conductscience.org/library/papers/18581754PubMed
1832698317Monoclonal Antibodies in Cancer Therapy.Antibodies (Basel)2020https://conductscience.org/library/papers/32698317PubMed
1933800717In Vivo Production of RNA Aptamers and Nanoparticles: Problems and Prospects.Molecules2021https://conductscience.org/library/papers/33800717PubMed
205319841Streptavidin--a substance with avidin-like properties produced by microorganisms.Biochem Biophys Res Commun1964https://conductscience.org/library/papers/5319841PubMed

See all 320 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42942844Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges.Pharmaceutics2026https://conductscience.org/library/papers/42942844PubMed
42700019Chitosan-based nanoparticles as a targeted drug delivery system to treat thyroid cancer: A literature review.Medicine (Baltimore)2026https://conductscience.org/library/papers/42700019PubMed
42699688Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential.Int J Nanomedicine2026https://conductscience.org/library/papers/42699688PubMed
42653769Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653769PubMed
42627480Theranostic Smart Bionanosensors for Solid Tumors: Advances, Challenges, and Future Directions.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/42627480PubMed
42620963Orthogonal functionalization of lithium niobate nanoparticles with targeting aptamers and caged chemotherapeutics.RSC Appl Interfaces2026https://conductscience.org/library/papers/42620963PubMed
42545662Sensitive detection of unopposed estrogen using estrogen receptor functionalized nanoprobes for cancer diagnosis.Discov Nano2026https://conductscience.org/library/papers/42545662PubMed
42460644Isothiocyanates in Cancer Therapeutics - A Molecular Perspective.Chem Biodivers2026https://conductscience.org/library/papers/42460644PubMed
42357313Cell-Specific Extracellular Vesicles Targeting Strategies for Immune Modulation in Inflammatory Diseases.Pharmaceutics2026https://conductscience.org/library/papers/42357313PubMed
42351104Virus-like particles in cancer immunotherapy: bridging human and veterinary medicine through one health.J Nanobiotechnology2026https://conductscience.org/library/papers/42351104PubMed
42260240Emerging paradigms in nanostructured targeted drug delivery systems.Discov Nano2026https://conductscience.org/library/papers/42260240PubMed
42232345Bio-based nanomaterials in drug delivery: An updated review.Pharm Sci Adv2026https://conductscience.org/library/papers/42232345PubMed
42071161Engineering microspheres for breast cancer: integrating tumor modeling, diagnostics, and targeted treatment.Daru2026https://conductscience.org/library/papers/42071161PubMed
41956789[Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/41956789PubMed
41922813Cationic lipid-based nanoparticles for therapeutic delivery in cancer treatment: physicochemical characteristics, therapeutic cargos, and clinical potential.Appl Microsc2026https://conductscience.org/library/papers/41922813PubMed
41710748Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/41710748PubMed
41499069Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy.Mol Diagn Ther2026https://conductscience.org/library/papers/41499069PubMed
41409587Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance.Bioimpacts2025https://conductscience.org/library/papers/41409587PubMed
41246347Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation.Front Immunol2025https://conductscience.org/library/papers/41246347PubMed
41184856Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions.Mol Cancer2025https://conductscience.org/library/papers/41184856PubMed

See all 27 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39940134

GET https://conductscience.org/api/papers/v1/39940134/references?page=2